参考文献/References:
[1]黄霄,郝兆虎,马菲.二甲双胍联合二肽基肽酶4抑制剂治疗未达标的2型糖尿病患者应用格列喹酮的疗效研究[J].中国实用内科杂志,2021,41(2):129-132.[2]Sa-Nguanmoo P,Tanajak P,Kerdphoo S,et al.SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats[J].Toxicology and Applied Pharmacology,2017,333:43-50.[3]戚蓓蓓,宋文春,江冬梅,等.二肽基肽酶-4抑制剂西格列汀联合二甲双胍治疗2型糖尿病的疗效[J].江苏医药,2016,42(15):1728-1729.[4]梁宇,焦秀敏,张星光,等.达格列净对超重2型糖尿病患者脂联素水平和体脂分布及骨矿含量的影响研究[J].中国全科医学,2021,24(21):2655-2660,2668.[5]何瑛.二肽基肽酶4抑制剂联合地特胰岛素治疗血糖控制不佳的2型糖尿病的疗效及对血糖和氧化应激指标的影响[J].中国基层医药,2021,28(5):715-719.[6]罗琼,徐文光,李琴,等.GLP-1RA、DPP-4抑制剂治疗2型糖尿病肥胖患者的疗效及其对心血管疾病发病风险的对比[J].心血管康复医学杂志,2021,30(2):159-164.[7]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.[8]徐爱花,黄建胜,何银辉,等.达格列净片治疗2型糖尿病血糖控制不佳患者的疗效与低血糖风险观察[J].中华全科医学,2020,18(9):1500-1503,1526.[9]高芳芳,张萍,钟兴,等.达格列净对血糖控制不佳的2型糖尿病患者血糖波动的影响[J].山东医药,2020,60(14):48-50.[10]Dekkers CCJ,Petrykiv S,Laverman GD,et al.Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers[J].Diabetes,Obesity and Metabolism,2018,20(8):1988-1993.[11]袁伟杰,管昊晨.钠-葡萄糖协同转运蛋白2抑制剂的肾脏获益:从理论到临床实践[J].肾脏病与透析肾移植杂志,2021,30(2):148-149.[12]曲建昌,弓月,王彤,等.达格列净联合二肽基肽酶4抑制剂和二甲双胍治疗血糖控制不佳2型糖尿病的效果分析[J].中国医药,2021,16(6):857-860.[13]邓宁,胡庆芬,梁彩虹,等.达格列净片联合盐酸二甲双胍对2型糖尿病患者的临床研究[J].中国临床药理学杂志,2019,35(18):2016-2018,2039.[14]李玉红,邵爽,孟旭英.二肽基肽酶4抑制剂维格列汀联合胰岛素治疗2型糖尿病的疗效及对超敏C反应蛋白影响的观察[J].中国糖尿病杂志,2019,27(9):658-661.[15]阳皓,谭巧灵,王岑,等.达格列净对早期2型糖尿病肾病患者尿微量白蛋白和促炎症因子的影响[J].华中科技大学学报(医学版),2019,48(4):400-404.[16]甄霞,顾红燕,文祯,等.达格列净联合胰岛素治疗特定2型糖尿病住院患者的疗效与安全性分析[J].中国医院药学杂志,2019,39(4):385-389.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(09):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Medical Information,2018,31(09):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Medical Information,2018,31(09):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(09):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Medical Information,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Medical Information,2018,31(09):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[7]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Medical Information,2018,31(09):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
[8]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(09):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[9]刘小红.长效胰岛素联合口服降糖药治疗2型糖尿病的
疗效与安全性评价[J].医学信息,2018,31(18):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
LIU Xiao-hong.Efficacy and Safety of Long Acting Insulin Combined with Oral Hypoglycemic Agents in Treatment of Type 2 Diabetes Mellitus[J].Medical Information,2018,31(09):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
[10]鲍 哲,杨升伟,柯赛赛,等.益生元对2型糖尿病患者糖脂代谢的影响[J].医学信息,2018,31(18):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]
BAO Zhe,YANG Sheng-wei,KE Sai-sai,et al.Effect of Prebiotics on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes mellitus[J].Medical Information,2018,31(09):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]